Literature DB >> 7482419

Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiologic and pathologic conditions. On behalf of the Subcommittee on Tissue factor Pathway Inhibitor (TFPI) of the Scientific and Standardization Committee of the ISTH.

B Osterud1, M S Bajaj, S P Bajaj.   

Abstract

Under normal conditions, TFPI expression is restricted to megakaryocytes and the endothelium of the microvasculature. It is not synthesized by normal hepatocytes or by the endothelium of larger vessels. In contrast, endothelium and peripheral blood cells do not express tissue factor under normal conditions. Expression of tissue factor under normal physiologic conditions is widespread and is localized in areas which are physically separated from the circulating blood. During an inflammatory response, circulating monocytes have been shown to express tissue factor, whereas in general, expression of tissue factor has not been observed in the endothelium. Adherent monocytes/macrophages express both tissue factor and TFPI under pathologic conditions. Whether or not circulating peripheral blood monocytes under inflammatory conditions express TFPI is not known.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7482419

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  18 in total

Review 1.  Effects of angiotensin converting enzyme inhibitors on thrombotic mediators: potential clinical implications.

Authors:  Seema A Kothari; Mytrang K Le; Pritesh J Gandhi
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300

Review 2.  Endothelial cell heterogeneity.

Authors:  William C Aird
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

3.  Expression and characterization of wild-type TFPI and the [P151L]TFPI mutant in insect cells.

Authors:  Elmar Thyzel; Sabine Siegling; Thomas Brinkmann; Knut Kleesiek; Christian Götting
Journal:  Mol Cell Biochem       Date:  2006-02       Impact factor: 3.396

4.  Sepsis and pathophysiology of anthrax in a nonhuman primate model.

Authors:  Deborah J Stearns-Kurosawa; Florea Lupu; Fletcher B Taylor; Gary Kinasewitz; Shinichiro Kurosawa
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

5.  Protein and mRNA expression of tissue factor pathway inhibitor-1 (TFPI-1) in breast, pancreatic and colorectal cancer cells.

Authors:  M A Kurer
Journal:  Mol Biol Rep       Date:  2006-12-19       Impact factor: 2.316

6.  Changes in coagulation and fibrinolytic parameters caused by extracorporeal circulation.

Authors:  R Grossmann; J Babin-Ebell; M Misoph; S Schwender; K Neukam; T Hickethier; O Elert; F Keller
Journal:  Heart Vessels       Date:  1996       Impact factor: 2.037

7.  Renal expression of tissue factor pathway inhibitor and evidence for a role in crescentic glomerulonephritis in rabbits.

Authors:  J H Erlich; J Apostolopoulos; T C Wun; K K Kretzmer; S R Holdsworth; P G Tipping
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

8.  JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms.

Authors:  S Leah Etheridge; Michelle E Roh; Megan E Cosgrove; Veena Sangkhae; Norma E Fox; Junmei Chen; José A López; Kenneth Kaushansky; Ian S Hitchcock
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

Review 9.  Biology and pathogenesis of thrombosis and procoagulant activity in invasive infections caused by group A streptococci and Clostridium perfringens.

Authors:  Amy E Bryant
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

Review 10.  Brain regulation of thrombosis and hemostasis: from theory to practice.

Authors:  Mark J Fisher
Journal:  Stroke       Date:  2013-10-01       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.